Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Timothy Steven Wach Insider Profile
4 Followers
Timothy Steven Wach, Director at Liminal BioSciences, holds 0.00 shares in Liminal BioSciences (Ticker: LMNL). Most recently, Timothy Steven Wach Sold $900 shares of Liminal BioSciences on Sep 27, 2023 for an estimated value of 7.65K.
Timothy Steven Wach Liminal BioSciences (LMNL)Director
Liminal BioSciences (LMNL)
Director
Not Ranked
Ranked #85,888 out of 98,624 Corporate Insiders
Timothy Steven Wach has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Timothy Steven Wach does not currently own shares as a corporate insider.
A breakdown of Timothy Steven Wach's holdings
Insider Roles
Timothy Steven Wach does not currently hold a role as a corporate insider.
Roles that Timothy Steven Wach holds in companies
Most Profitable Insider Trade
Stock:
Liminal BioSciences
(LMNL)
(LMNL)
Rating:Informative Buy
Date:Mar 25, 2022 - Mar 25, 2023
Return:-62.60%
The most profitable trade made by Timothy Steven Wach
Timothy Steven Wach's Trading History
List of latest transactions for each holding click on a transaction to see Timothy Steven Wach's performance on stock
You May Also Like
Timothy Steven Wach insider profile FAQ
What is the percentage of profitable transactions made by Timothy Steven Wach?
The percentage of profitable transactions made by Timothy Steven Wach is ―.
What is the average return per transaction made by Timothy Steven Wach?
The average return per transaction made by Timothy Steven Wach is ―.
What stocks does Timothy Steven Wach hold?
Timothy Steven Wach holds: LMNL stocks.
What was Timothy Steven Wach’s latest transaction?
Timothy Steven Wach latest transaction was an Informative Sell of $7.65K.
What was Timothy Steven Wach's most profitable transaction?
Timothy Steven Wach’s most profitable transaction was an Informative Buy of LMNL stock on March 25, 2022. The return on the trade was -62.60%.
What is Timothy Steven Wach's role in Liminal BioSciences?
Timothy Steven Wach's role in Liminal BioSciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.